quinazolines has been researched along with Migraine with Aura in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kayama, Y; Kitagawa, S; Nakahara, J; Shibata, M; Takizawa, T; Tang, C; Unekawa, M | 1 |
| Vetter, C | 1 |
2 other study(ies) available for quinazolines and Migraine with Aura
| Article | Year |
|---|---|
Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Cortex; Chronic Pain; Cortical Spreading Depression; Dipeptides; Electrodes; Face; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Migraine with Aura; Movement; Photophobia; Piperazines; Prevalence; Quinazolines; Receptors, Serotonin; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Temperature | 2020 |
[Migraine can signal a risk for heart and brain].
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Female; Humans; Imidazoles; Migraine Disorders; Migraine with Aura; Myocardial Infarction; Piperazines; Quinazolines; Risk Factors; Stroke; Tryptamines | 2009 |